Literature DB >> 11096492

Acute Pulmonary Edema.

.   

Abstract

Patients with acute cardiogenic pulmonary edema require rapid assessment and therapy to prevent progression to respiratory failure and cardiovascular collapse. The goal of therapy is to decrease the pulmonary capillary wedge pressure by decreasing intravascular volume and shifting the blood volume into peripheral vascular beds. Mainstays of therapy include morphine sulfate (a venodilator and an anxiolytic), furosemide (a venodilator and diuretic), nitroglycerin preparations (venodilators), and, in some cases, aminophylline, nitroprusside, and beta-adrenergic agents or milrinone. Patients who do not respond to more conservative measures may require interventional procedures, including Swan-Ganz catheterization or arterial pressure monitoring, continuous positive airway pressure or mechanical ventilation, intra- aortic balloon counterpulsation, and mechanical removal of fluid. Because the prognosis for patients with acute cardiogenic pulmonary edema depends on identification and correction of the underlying disease process, it is essential to define the cause of the edema during and after stabilization of the patient. Evaluation should include Doppler echocardiography, cardiac catheterization, and coronary angiography.

Entities:  

Year:  1999        PMID: 11096492     DOI: 10.1007/s11936-999-0043-3

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  14 in total

1.  Experience with the use of continuous positive airway pressure (CPAP) therapy in the emergency management of acute severe cardiogenic pulmonary oedema.

Authors:  A M Kelly; C Georgakas; S Bau; P Rosengarten
Journal:  Aust N Z J Med       Date:  1997-06

2.  Guidelines for cardiopulmonary resuscitation and emergency cardiac care. Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Part III. Adult advanced cardiac life support.

Authors: 
Journal:  JAMA       Date:  1992-10-28       Impact factor: 56.272

3.  Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.

Authors:  G Cotter; E Metzkor; E Kaluski; Z Faigenberg; R Miller; A Simovitz; O Shaham; D Marghitay; M Koren; A Blatt; Y Moshkovitz; R Zaidenstein; A Golik
Journal:  Lancet       Date:  1998-02-07       Impact factor: 79.321

4.  The effect of nasal continuous positive airway pressure on plasma endothelin-1 concentrations in patients with severe cardiogenic pulmonary edema.

Authors:  S Takeda; T Takano; R Ogawa
Journal:  Anesth Analg       Date:  1997-05       Impact factor: 5.108

5.  Intravenous nitroglycerin boluses in treating patients with cardiogenic pulmonary edema.

Authors:  A H Nashed; J R Allegra
Journal:  Am J Emerg Med       Date:  1995-09       Impact factor: 2.469

6.  Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure).

Authors: 
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

7.  Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Short-term results and long-term follow-up.

Authors:  M Lin; Y F Yang; H T Chiang; M S Chang; B N Chiang; M D Cheitlin
Journal:  Chest       Date:  1995-05       Impact factor: 9.410

8.  Isolated ultrafiltration in cardiogenic pulmonary edema.

Authors:  G Susini; M Zucchetti; F Bortone; L Salvi; C M Cipolla; A Rimondini; E Sisillo
Journal:  Crit Care Med       Date:  1990-01       Impact factor: 7.598

Review 9.  Acute cardiogenic pulmonary edema.

Authors:  M A Gropper; J P Wiener-Kronish; S Hashimoto
Journal:  Clin Chest Med       Date:  1994-09       Impact factor: 2.878

Review 10.  Congestive heart failure and pulmonary edema for the emergency physician.

Authors:  R E Fromm; J Varon; L R Gibbs
Journal:  J Emerg Med       Date:  1995 Jan-Feb       Impact factor: 1.484

View more
  1 in total

1.  Risk Factors and Management for Biliary Complications Following Adult Living-Donor Liver Transplantation.

Authors:  Tsukasa Nakamura; Taku Iida; Hidetaka Ushigome; Masafumi Osaka; Koji Masuda; Takehisa Matsuyama; Shumpei Harada; Shuji Nobori; Norio Yoshimura
Journal:  Ann Transplant       Date:  2017-11-08       Impact factor: 1.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.